A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open-Label Long Term Extension to Evaluate the S

A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open-Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis (PSC)

Open

Protocol code: CLIN-60190-453
EudraCT code: 2022-002695-37
Research group: Liver Diseases
Service: Hepatology
Principal investigator: Campos Varela, Isabel
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase II
Status: Recruiting volunteers